Remick D G, Garg S J, Newcomb D E, Wollenberg G, Huie T K, Bolgos G L
Department of Pathology, University of Michigan, Ann Arbor 48109-0602, USA.
Crit Care Med. 1998 May;26(5):895-904. doi: 10.1097/00003246-199805000-00025.
To determine if exogenous interleukin (IL)-10 will decrease the morbidity or mortality of sepsis induced by cecal ligation and puncture.
Prospective, randomized, controlled study.
University research laboratory.
Adult, female, Balb¿c mice.
Balb¿c mice were subjected to cecal ligation and puncture with an 18- or 23-gauge needle and treated with triple antibiotics. Mice were injected subcutaneously with recombinant human IL-10 (diluted in normal saline with 0.1% mouse serum albumin) and followed until death. In a separate experiment, IL-10 was also injected subcutaneously and lipopolysaccharide (LPS) injected intraperitoneally and plasma tumor necrosis factor concentrations measured 90 mins later.
In the LPS experiments, IL-10 decreased tumor necrosis factor (TNF) production by nearly 90%. For the cecal ligation and puncture experiments, temperature and movement were recorded continuously via implanted transmitters. Studies on mortality indicated that exogenous IL-10 given at 0, +6 and +12 hrs after surgery failed to increase survival when using an 18-gauge needle (alive:total cecal ligation and puncture alone 4:21; IL-10 10 microg/mouse 2:12; 1 microg/mouse 8:25; 0.1 microg/mouse 1:12) or a 23-gauge needle (cecal ligation and puncture alone 13:29; IL-10 1 microg 18:30). There was no difference in the number of hours to death between the groups. IL-10 did not prevent the hypothermia after cecal ligation and puncture or increase the animals' activity. To examine parameters of inflammation, mice were killed 8 hrs after 18-gauge cecal ligation and puncture. IL-10 (1 microg/mL) failed to reduce pulmonary neutrophil sequestration (lung myeloperoxidase, cecal ligation and puncture 107 +/- 10 [SEM], IL-10 107 +/- 5) or recruitment of neutrophils to the peritoneum (neutrophils x 10(6), cecal ligation and puncture 3.72 +/- 0.62; IL-10 3.49 +/- 0.37). IL-10 also failed to reduce the appearance of TNF or IL-6 in the plasma or peritoneal fluid. The chemokine KC was reduced in the peritoneal fluid but not the plasma and endogenous IL-10 production was not reduced in the peritoneum.
Our data indicate that exogenous IL-10 fails to improve morbidity or mortality in the clinically relevant cecal ligation and puncture model of sepsis.
确定外源性白细胞介素(IL)-10是否会降低盲肠结扎穿刺诱导的脓毒症的发病率或死亡率。
前瞻性、随机、对照研究。
大学研究实验室。
成年雌性Balb/c小鼠。
用18号或23号针头对Balb/c小鼠进行盲肠结扎穿刺,并给予三联抗生素治疗。小鼠皮下注射重组人IL-10(用含0.1%小鼠血清白蛋白的生理盐水稀释),并观察至死亡。在另一项实验中,也皮下注射IL-10,腹腔注射脂多糖(LPS),90分钟后测量血浆肿瘤坏死因子浓度。
在LPS实验中,IL-10使肿瘤坏死因子(TNF)产生减少近90%。对于盲肠结扎穿刺实验,通过植入的发射器连续记录体温和活动情况。死亡率研究表明,在手术后0、+6和+12小时给予外源性IL-10,使用18号针头时未能提高生存率(存活:单纯盲肠结扎穿刺4:21;IL-10 10μg/小鼠2:12;1μg/小鼠8:25;0.1μg/小鼠1:12)或23号针头时(单纯盲肠结扎穿刺13:29;IL-10 1μg 18:30)。各组之间死亡时间的小时数无差异。IL-10不能预防盲肠结扎穿刺后的体温过低或增加动物的活动。为了检测炎症参数,在18号盲肠结扎穿刺8小时后处死小鼠。IL-10(1μg/mL)未能减少肺内中性粒细胞滞留(肺髓过氧化物酶,盲肠结扎穿刺107±10[标准误],IL-10 107±5)或中性粒细胞向腹膜的募集(中性粒细胞×10⁶,盲肠结扎穿刺3.72±0.62;IL-10 3.49±0.37)。IL-10也未能减少血浆或腹膜液中TNF或IL-6的出现。趋化因子KC在腹膜液中减少但在血浆中未减少,腹膜内源性IL-10产生未减少。
我们的数据表明,在临床相关的盲肠结扎穿刺脓毒症模型中,外源性IL-10未能改善发病率或死亡率。